Here, TMZ downregulated IDO1 in three of five GBM cell lines but led to increased expression in HROG52 and HROG63—a paired GBM cell line established from the very same patient (primary lesion and upon relapse) (Figure 4). Here, IDO1 is linked to glioblastoma.